How well do health systems monitor HIV-associated comorbidities? HIV Outcomes at HIV Drug Therapy Glasgow 2018
News
25 October 2018

How well do health systems monitor HIV-associated comorbidities? HIV Outcomes at HIV Drug Therapy Glasgow 2018

Steering group co-chair Professor Jane Anderson (Consultant Physician, Homerton University Hospital, London) will present findings from HIV Outcomes' assessment of how effectively health systems are monitoring HIV-associated comorbidities at this year's HIV Drug Therapy conference in Glasgow on 28-31 October 2018.

While HIV has become a chronic condition, evidence suggests that there are a growing number of people living with HIV suffering from non-AIDS-defining comorbidities. Using current global and European frameworks, the HIV Outcomes abstract assesses whether existing monitoring frameworks sufficiently enable European countries to observe and understand the comorbidities that impact on the health and well-being of people living with HIV.

The abstract is taken from research work being undertaken by the HIV Outcomes study group.

More updates All

News
03 April 2019
Findings from six European countries – Estonia, Italy, the Netherlands, Slovenia, Sweden and Turkey – show that collectively, countries have prominent monitoring gaps across key domains of HIV care, including psychosocial services, comorbidities and discrimination within health systems. HIV Outcomes suggests collecting ...
More
News
21 December 2018
Thank you very much for your support this year! 2018 has been busy for HIV Outcomes! In an effort to achieve better long-term health outcomes and quality of life for people living with HIV, this year the HIV Outcomes initiative road-tested ...
More
Report
27 November 2018
The HIV Outcomes Steering Group ‘road-tested’ the HIV Outcomes recommendations in Italy and Sweden this year to confirm that they are fit for implementation.
More
Filters
Initiative Partners
  • Aids Action Europe
  • AFEW International
  • East Europe and Central Asia Union of PLWH
  • European AIDS Treatment Group
  • Gilead
  • ViiV Healthcare
This initiative is enabled by sponsorship provided by Gilead Sciences and ViiV Healthcare.